DUOPHARMA BIOTECH |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.2 MYR | -1.64% |
|
-2.44% | -4.76% |
| 05-24 | Duopharma’s Attributable Income Shrinks in Q1; Shares Down 2% | MT |
| 05-23 | Duopharma Biotech Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 245M | ||||||
| 41.97B | ||||||
| 22.34B | ||||||
| 15.25B | ||||||
| 14B | ||||||
| 12.06B |
